ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis B
NCT01633554 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 95
Last updated 2012-07-04
Summary
IL-33 is a recently identified number of the IL-1 family. Hepatic over-expression of IL-33 has been recently linked to liver fibrosis. ST-2 exerts pro-inflammatory effects of IL-33. We aimed to determine ability of ST2 to predict fibrosis in chronic hepatitis B.
Conditions
- Sequela of Chronic Liver Disease
Sponsors & Collaborators
-
Turkiye Yuksek Ihtisas Education and Research Hospital
lead OTHER_GOV
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-01-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-09-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
FGL2/Fibroleukin and Hepatitis C Virus Recurrence Post Liver Transplantation
NCT00701272 ·Status: UNKNOWN
-
Cytokines and the Risk of Infection in Liver Cirrhosis
NCT00857181 ·Status: TERMINATED
-
Immun Status at Pancreatitis Patients
NCT03937323 ·Status: COMPLETED
-
Il-17 Levels in Intrahepatic Cholestasis of Pregnancy
NCT01898832 ·Status: UNKNOWN
-
Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
NCT00499434 ·Status: UNKNOWN
-
Albumin Modifications as Early Biomarkers of Chronic Liver Diseases
NCT06318949 ·Status: RECRUITING ·Phase: NA
-
MRI Based Biomarkers in Pediatric Autoimmune Liver Disease
NCT03175471 ·Status: RECRUITING
-
MRI Biomarkers in as Predictor of Clinical Endpoints in Pediatric Autoimmune Liver Disease
NCT03178630 ·Status: RECRUITING
-
Cell Bound Complement Activation Proteins as Markers of Liver Injury
NCT01025531 ·Status: WITHDRAWN
-
sgp130 in Chronic Human Liver Disease
NCT00770198 ·Status: COMPLETED
-
Immune Dysregulation in Hepatitis C Patients With or Without Arthritis
NCT01195987 ·Status: UNKNOWN
-
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients
NCT01672164 ·Status: COMPLETED
-
Study IL- 35 Level and Fibronectin Type Ⅲ Domain Containing Protein 5 \ Irsin (FNDC5 rs3480) Gene Variations in Chronic Hepatitis B.
NCT06023745 ·Status: UNKNOWN
-
How Sirtuin Levels Change During Behçet Disease
NCT06266247 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Discrimination of DILI and AIH by Artificial Intelligence
NCT05532345 ·Status: COMPLETED
-
Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors
NCT06470997 ·Status: RECRUITING
-
Prohepcidin, Inflammation and Iron Homeostasis in Hemodialysis Patients With Chronic Hepatitis C
NCT01272479 ·Status: COMPLETED
-
Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease
NCT02128503 ·Status: TERMINATED ·Phase: NA
-
Fetuin A in Hashimoto Thyroiditis
NCT01884649 ·Status: COMPLETED
-
Novel Biomarkers in Assessment of Interstitial Lung Disease Associated With Rheumatoid Arthritis Patients
NCT07003451 ·Status: NOT_YET_RECRUITING
-
S100A8/A9 and Innate Immunity in Liver Disease
NCT05793983 ·Status: UNKNOWN
-
FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy
NCT00606528 ·Status: COMPLETED
-
Autoimmune Hepatitis Study
NCT00286663 ·Status: TERMINATED
-
Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients At Assiut University Hospital
NCT06601361 ·Status: NOT_YET_RECRUITING
-
Immunological Measurement of Aspartate/Alanine Aminotransferase
NCT03562585 ·Status: COMPLETED